ConductScience.org, home

Trial · NCT06866509

Registered outcomes57

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in LDL-C Levels Compared to Baselineat Week 24Change in LDL-C Levels at Week 24 Compared to Baseline
SecondaryChanges in LDL-C levels compared to baseline [excluding primary endpoints].at Week 12Changes in LDL-C levels at Week 12 compared to baseline \[excluding primary endpoints\].
SecondaryPercentage changes (%) in LDL-C levels compared to baseline [excluding primary endpoints].at Week 12Percentage changes (%) in LDL-C levels at Week 12 compared to baseline \[excluding primary endpoints\].
SecondaryChanges in LDL-C levels compared to baseline [excluding primary endpoints].at Week 24Changes in LDL-C levels at Week 24 compared to baseline \[excluding primary endpoints\].
SecondaryPercentage changes (%) in LDL-C levels compared to baseline [excluding primary endpoints].at Week 24Percentage changes (%) in LDL-C levels at Week 24 compared to baseline \[excluding primary endpoints\].
SecondaryChanges in HDL-C levels compared to baselineat Week 12Changes in HDL-C levels at Week 12 compared to baseline.
SecondaryPercentage changes (%) in HDL-C levels compared to baselineat Week 12Percentage changes (%) in HDL-C levels at Week 12 compared to baseline.
SecondaryChanges in HDL-C levels compared to baselineat Week 24Changes in HDL-C levels at Week 24 compared to baseline.
SecondaryPercentage changes (%) in HDL-C levels compared to baselineat Week 24Percentage changes (%) in HDL-C levels at Week 24 compared to baseline.
SecondaryChanges in Non-HDL-C levels compared to baselineat Week 12Changes in Non-HDL-C levels at Week 12 compared to baseline
SecondaryPercentage changes (%) in Non-HDL-C levels compared to baselineat Week 12Percentage changes (%) in Non-HDL-C levels at Week 12 compared to baseline
SecondaryChanges in Non-HDL-C levels compared to baselineat Week 24Changes in Non-HDL-C levels at Week 24 compared to baseline
SecondaryPercentage changes (%) in Non-HDL-C levels compared to baselineat Week 24Percentage changes (%) in Non-HDL-C levels at Week 24 compared to baseline
SecondaryChanges in TG levels compared to baselineat Week 12Changes in TG levels at Week 12 compared to baseline.
SecondaryPercentage changes (%) in TG levels compared to baselineat Week 12Percentage changes (%) in TG levels at Week 12 compared to baseline.
SecondaryChanges in TG levels compared to baselineat Week 24Changes in TG levels at Week 24 compared to baseline
SecondaryPercentage changes (%) in TG levels compared to baselineat Week 24Percentage changes (%) in TG levels at Week 24 compared to baseline
SecondaryChanges in TC levels compared to baselineat Week 12Changes in TC levels at Week 12 compared to baseline
SecondaryPercentage changes (%) in TC levels compared to baselineat Week 12Percentage changes (%) in TC levels at Week 12 compared to baseline
SecondaryChanges in TC levels compared to baselineat Week 24Changes in TC levels at Week 24 compared to baseline

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06866509/registered